Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Conditions

• Previously Treated PH + CML

Interventions

• DRUG: Bosutinib

Sponsor

Pfizer

Collaborators

• [object Object]